NEW YORK (GenomeWeb) – Meridian Bioscience today reported flat fiscal fourth quarter revenues and a 1 percent increase in fiscal year 2016 revenues.
The results were consistent with preliminary earnings announced last month that sent the firm's stock tumbling.